Trade VTVT anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
vTv Therapeutics Inc. Class A (VTVT) is trading at US$33.35, down 0.36% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$131.49M. Over the past 52 weeks, VTVT has traded between US$18.76 and US$44.00. On Syfe you can trade VTVT with $0 commission and add it to your watchlist.
| Previous close | US$33.47 |
|---|---|
| Market cap | US$131.49M |
| 52-week range | US$18.76 – US$44.00 |
| Volume | 12.07K |
| Exchange | US |
Add to Watchlist
Set Price Alert
vTv Therapeutics Inc. Class A
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and the Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.
Year: 2015
Evercore ISI Initiates vTv Therapeutics at Outperform With $44 Price Target
Mar 12, 11:38 AM · MT Newswires
vTv Therapeutics Inc. Class A (VTVT) stock is trading at US$33.35, -0.36% from the previous close of US$33.47.
The market cap for vTv Therapeutics Inc. Class A (VTVT) stock is approximately US$131.49M.
The 52-week high for vTv Therapeutics Inc. Class A (VTVT) stock is US$44.00.
The 52-week low for vTv Therapeutics Inc. Class A (VTVT) stock is US$18.76.
vTv Therapeutics Inc. Class A (VTVT) does not currently pay a dividend.
Stay on top of VTVT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
